Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 103.57B | $ 40.17B | $ 26.57B | $ 28.46B | $ 21.75B |
Total Assets | $ 399.18B | $ 245.65B | $ 255.80B | $ 203.18B | $ 191.32B |
Total Debt | $ 12.35B | $ 165.20B | $ 157.44B | $ 122.66B | $ 120.88B |
Net Debt | $ -91.21B | $ 125.03B | $ 130.87B | $ 94.20B | $ 99.13B |
Total Liabilities | $ 370.37B | $ 223.30B | $ 234.02B | $ 184.82B | $ 173.15B |
Stockholders Equity | $ 28.56B | $ 22.05B | $ 21.06B | $ 17.76B | $ 16.36B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |